1477 Results

People

  1. Motzer
    Motzer
  2. Hudis
    Hudis
  3. Aghajanian
    Aghajanian
  4. O'Reilly
    O'Reilly
  5. Kris
    Kris
  6. Scher
    Scher
  7. Panageas
    Panageas
  8. Saltz
    Saltz
  9. Schwartz
    Schwartz
  10. Kelsen
    Kelsen

Groups

  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)
  7. Epidemiology and Biostatistics (194)
  8. Biostatistics Service (169)
  9. Gastrointestinal Oncology Service (160)
  10. Population Sciences Research Program (158)
  1. "fatigue"
Formats
  1. Journal Article (1402)
  2. Review (38)
  3. Research Letter (13)
  4. Editorial (10)
  5. Conference Paper (5)
  6. Guidelines (4)
  7. Correspondence (3)
  8. Book Section (2)
Groups
  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)

More Groups

People
  1. Robert Motzer (85)
  2. Clifford Hudis (49)
  3. Carol Aghajanian (46)
  4. Eileen O'Reilly (46)
  5. Howard Scher (44)
  6. Mark Kris (44)

More People

Years
  1. 2025 (60)
  2. 2024 (132)
  3. 2023 (89)
  4. 2022 (46)
  5. 2021 (33)
  6. 2020 (85)

More Years

Publications
  1. Journal of Clinical Oncology (108)
  2. Clinical Cancer Research (82)
  3. Cancer (63)
  4. Lancet Oncology (50)
  5. Gynecologic Oncology (41)
  6. Annals of Oncology (37)

More Publications

Publishers
  1. Elsevier Inc. (244)
  2. Springer (133)
  3. American Society of Clinical Oncology (114)
  4. Elsevier Science, Inc. (108)
  5. Oxford University Press (101)
  6. American Association for Cancer Research (89)

More Publishers

Results (1477)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • B7H3-directed intraperitoneal radioimmunotherapy with radioiodinated omburtamab for desmoplastic small round cell tumor and other peritoneal tumors: Results of a phase I study
    Journal Article

    Modak, S.; Zanzonico, P.; Grkovski, M.; Slotkin, E. K.; Carrasquillo, J. A.; Lyashchenko, S. K.; Lewis, J. S.; Cheung, I. Y.; Heaton, T.; LaQuaglia, M. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Outcomes of patients with hematologic malignancies and COVID-19: A report from the ASH Research Collaborative Data Hub
    Journal Article

    Wood, W. A.; Neuberg, D. S.; Colton Thompson, J.; Tallman, M. S.; Sekeres, M. A.; Sehn, L. H.; Anderson, K. C.; Goldberg, A. D.; Pennell, N. A.; Niemeyer, C. M.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Determining the recommended dose of pacritinib: Results from the PAC203 dose-finding trial in advanced myelofibrosis
    Journal Article

    Gerds, A. T.; Savona, M. R.; Scott, B. L.; Talpaz, M.; Egyed, M.; Harrison, C. N.; Yacoub, A.; Vannucchi, A.; Mead, A. J.; Kiladjian, J. J.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: Long-term follow-up and biomarker analysis
    Journal Article

    Noy, A.; de Vos, S.; Coleman, M.; Martin, P.; Flowers, C. R.; Thieblemont, C.; Morschhauser, F.; Collins, G. P.; Ma, S.; Peles, S.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • A multicenter randomized three-arm phase II study of (1) everolimus, (2) estrogen deprivation therapy (EDT) with leuprolide + letrozole, and (3) everolimus + EDT in patients with unresectable fibrolamellar carcinoma
    Journal Article

    El Dika, I.; Mayer, R. J.; Venook, A. P.; Capanu, M.; LaQuaglia, M. P.; Kobos, R.; O'Neill, A. F.; Chou, J. F.; Ly, M.; Ang, C.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • Tazemetostat for patients with relapsed or refractory follicular lymphoma: An open-label, single-arm, multicentre, phase 2 trial
    Journal Article

    Morschhauser, F.; Tilly, H.; Chaidos, A.; McKay, P.; Phillips, T.; Assouline, S.; Batlevi, C. L.; Campbell, P.; Ribrag, V.; Damaj, G. L.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: An international, open-label, phase 2 basket study
    Journal Article

    Gounder, M.; Schöffski, P.; Jones, R. L.; Agulnik, M.; Cote, G. M.; Villalobos, V. M.; Attia, S.; Chugh, R.; Chen, T. W. W.; Jahan, T.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Excellent outcomes with surgery or radiotherapy in the management of Castleman disease including a case of oligocentric disease
    Journal Article

    Beckham, T. H.; Yang, J. C.; Chau, K. W.; Noy, A.; Yahalom, J.
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Comprehensive molecular genetic studies of Epstein-Barr virus-negative aggressive Natural killer-cell leukemia/lymphoma
    Journal Article

    Gao, J.; Zhang, Y.; Yaseen, N. R.; Fang, Y.; Lu, X.; Sukhanova, M.; Chen, Q.; Chen, Y. H.
    Human Pathology (2020)

    Fulltext@MSK | Save
  • Temporary organ displacement to escalate radiation dose to retroperitoneal tumors and decrease toxicity to organs at risk
    Journal Article

    Maybody, M.; Soliman, M. M.; Yamada, Y.; Tahour, D.; Hsu, M.; Moskowitz, C. S.; Katsoulakis, E.; Solomon, S. B.
    Journal of Vascular and Interventional Radiology (2020)

    Fulltext@MSK | Save